TSCAN THERAPEUTICS IN

TScan Therapeutics Announces Upcoming Trial in Progress Poster Presentation at the 2023 American Society of Clinical Oncology Annual Meeting

01 6 2023 15:10:00 提供 Nasdaq GlobeNewswire

TScan Therapeutics Announces Closing of Public Offering

01 6 2023 15:05:35 提供 Nasdaq GlobeNewswire

TScan Therapeutics to Participate in the Jefferies Healthcare Conference

01 6 2023 06:00:00 提供 Nasdaq GlobeNewswire

TScan Therapeutics Announces Pricing of $140 Million Public Offering

25 5 2023 23:37:03 提供 Nasdaq GlobeNewswire

TScan Therapeutics Announces Launch of Proposed Public Offering

25 5 2023 15:06:50 提供 Nasdaq GlobeNewswire

TScan Therapeutics Appoints Gavin MacBeath, Ph.D. as Chief Executive Officer and as a Member of the Board of Directors

24 5 2023 15:13:47 提供 Nasdaq GlobeNewswire

TScan Therapeutics Presents Preliminary Phase 1 Clinical Results on TSC-100 and TSC-101 at the American Society of Gene & Cell Therapy 26th Annual Meeting

17 5 2023 06:00:00 提供 Nasdaq GlobeNewswire

TScan Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update

10 5 2023 06:00:01 提供 Nasdaq GlobeNewswire

Amgen and TScan Therapeutics Announce Collaboration to Identify Novel Targets in Crohn’s Disease

09 5 2023 08:00:01 提供 Nasdaq GlobeNewswire

TScan Therapeutics Announces Upcoming Trial in Progress Poster Presentation at the American Society of Gene and Cell Therapy 26th Annual Meeting

02 5 2023 15:42:10 提供 Nasdaq GlobeNewswire

TScan Therapeutics Announces Appointment of Barbara Klencke, M.D., to its Board of Directors

10 4 2023 06:00:00 提供 Nasdaq GlobeNewswire

TScan Therapeutics Announces CEO Transition

31 3 2023 07:00:00 提供 Nasdaq GlobeNewswire

TScan Therapeutics Announces First Patient Dosed in Phase 1 Umbrella Clinical Trial Evaluating TSC-100 and TSC-101 for the Treatment of Hematologic Malignancies

14 3 2023 06:00:00 提供 Nasdaq GlobeNewswire

TScan Therapeutics to Participate in the Barclays Global Healthcare Conference

13 3 2023 15:05:00 提供 Nasdaq GlobeNewswire

TScan Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Highlights Upcoming Milestones

08 3 2023 06:00:01 提供 Nasdaq GlobeNewswire

TScan Therapeutics to Participate in the Cowen 43rd Annual Health Care Conference

01 3 2023 06:00:01 提供 Nasdaq GlobeNewswire

TScan Therapeutics Announces Presentation at the H.C. Wainwright Cell Therapy Virtual Conference

21 2 2023 06:00:01 提供 Nasdaq GlobeNewswire

TScan Therapeutics Announces FDA Clearance of Three Investigational New Drug Applications for the Treatment of Solid Tumors

23 1 2023 06:00:00 提供 Nasdaq GlobeNewswire

TScan Therapeutics Announces 2023 Clinical Plans and Highlights Recent Progress

05 1 2023 06:00:00 提供 Nasdaq GlobeNewswire

TScan Therapeutics Presents Phase 1 Umbrella Trial in Progress on HA-1 (TSC-100) and HA-2 (TSC-101) at the 64th American Society of Hematology Annual Meeting 2022

12 12 2022 06:00:00 提供 Nasdaq GlobeNewswire